← Leaderboards
Guanshu Liu
Hugo W. Moser Res Inst Kennedy Krieger
$4,246,793
Attributed
$5,105,859
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $868.8K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,105,859 · 7
By mechanism
R01$2,886,875 · 2
R33$966,399 · 1
R21$784,552 · 2
R41$306,433 · 1
R03$161,600 · 1
Top collaborators
- Renyuan Bai4 shared
- Yuancheng Li1 shared
Others in their field
Top investigators on “Monitor”
- Jeffrey P Krischer · University Of South Florida$631,818,376
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$476,087,269
- Bambra Strokes · Ppd Development Lp$461,655,950
- David Heimbrook · Leidos Biomedical Research, Inc.$367,240,481
- Lawrence Corey · Fred Hutchinson Cancer Center$302,301,802
Research focus
MonitorMagnetic Resonance ImagingPublic HealthTechnologyImageNon-Invasive ImagingImaging TechnologyUnited States National Institutes Of HealthTumorInnovationProtocols DocumentationMissionCellsPharmaceutical PreparationsSignal TransductionTranslatingBaseLabelDetectionSuccessTranslationsAnimal ModelResponseClinical Trials
Grant awards (17)
Multimodal MRI for guiding bacterial cancer therapy$382,342
R01 · FY2025 · CA · contact PI
Multi-functional magnetic nanorods for constructing theranostic extracellular vesicles for treating myocardial infarction$306,433
R41 · FY2024 · HL
Multimodal MRI for guiding bacterial cancer therapy$283,780
R01 · FY2024 · CA · contact PI
MPI/MRI bimodal imaging for non-invasive tracking of extracellular vesicles targeted to infarcted myocardium$479,328
R33 · FY2023 · HL · contact PI
Multimodal MRI for guiding bacterial cancer therapy$363,887
R01 · FY2023 · CA · contact PI
MPI/MRI bimodal imaging for non-invasive tracking of extracellular vesicles targeted to infarcted myocardium$487,071
R33 · FY2022 · HL · contact PI
Multimodal MRI for guiding bacterial cancer therapy$381,690
R01 · FY2022 · CA · contact PI
Noninvasive prediction of tumor response to gemcitabine using MRI$373,288
R01 · FY2020 · CA · contact PI
Noninvasive prediction of tumor response to gemcitabine using MRI$358,295
R01 · FY2019 · CA · contact PI
Noninvasive prediction of tumor response to gemcitabine using MRI$368,715
R01 · FY2018 · CA · contact PI
CEST MRI assessment of tumor vascular permeability using non-labeled dextrans$175,782
R21 · FY2018 · CA · contact PI
Noninvasive prediction of tumor response to gemcitabine using MRI$374,878
R01 · FY2017 · CA · contact PI
CEST MRI assessment of tumor vascular permeability using non-labeled dextrans$175,782
R21 · FY2017 · CA · contact PI
Optimization of CEST MRI for detection of bacteria$80,800
R03 · FY2017 · EB · contact PI
Optimization of CEST MRI for detection of bacteria$80,800
R03 · FY2016 · EB · contact PI
Monitoring Prodrug Delivery in Suicide Gene Therapy Using CEST MRI$190,537
R21 · FY2013 · EB · contact PI
Monitoring Prodrug Delivery in Suicide Gene Therapy Using CEST MRI$242,451
R21 · FY2012 · EB · contact PI